Differentiated Thyroid Cancer (DTC)

Also known as: DTC - Differentiated Thyroid Cancer / Differentiated Thyroid Cancer / Differentiated thyroid carcinoma (disorder) / Primary differentiated carcinoma of thyroid gland (disorder)

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB09100Thyroid, porcine1Completed1
DB00024Thyrotropin alfa1Completed1
DB11595Atezolizumab1 / 2Active Not Recruiting1
DB05153Cabozantinib1 / 2Active Not Recruiting1
DB08875Cabozantinib1 / 2Active Not Recruiting1
DB00773Etoposide1 / 2Completed1
DB01181Ifosfamide1 / 2Completed1
DB09078Lenvatinib1 / 2Completed1
DB11836Sapanisertib1 / 2Completed1
DB00024Thyrotropin alfa1 / 2Completed1
DB11885Anlotinib2Active Not Recruiting1
DB15414CM-43072Completed1
DB08875Cabozantinib2Active Not Recruiting1
DB08875Cabozantinib2Recruiting1
DB08875Cabozantinib2Terminated1
DB01590Everolimus2Active Not Recruiting1
DB11891Fimepinostat2Terminated1
DB05382Iodine2Active Not Recruiting1
DB14723Larotrectinib2Recruiting1
DB09078Lenvatinib2Recruiting1
DB09078Lenvatinib2Terminated1
DB09079Nintedanib2Completed1
DB09037Pembrolizumab2Recruiting1
DB12893Sacituzumab govitecan2Not Yet Recruiting1
DB00398Sorafenib2Active Not Recruiting1
DB00398Sorafenib2Terminated1
DB01268Sunitinib2Completed1
DB15106Surufatinib2Recruiting1
DB00024Thyrotropin alfa2Active Not Recruiting1
DB05294Vandetanib2Terminated1
DB11885Anlotinib2 / 3Unknown Status1
DB15414CM-43073Terminated1
DB08875Cabozantinib3Active Not Recruiting1
DB08912Dabrafenib3Recruiting1
DB05382Iodine3Terminated1
DB09078Lenvatinib3Completed1
DB14765Rivoceranib3Active Not Recruiting1
DB11689Selumetinib3Terminated1
DB09100Thyroid, porcine3Completed1
DB00024Thyrotropin alfa3Completed2
DB00024Thyrotropin alfa3Recruiting1
DB08911Trametinib3Recruiting1
DB05294Vandetanib3Completed1
DB00630Alendronic acidNot AvailableCompleted1
DB09078LenvatinibNot AvailableApproved for Marketing1
DB09078LenvatinibNot AvailableRecruiting1
DB14227Technetium Tc-99mNot AvailableCompleted1